The combination of plasma-derived FVIII/VWF with emicizumab has non-additive effects on thrombin generation assay independently of the presence of inhibitors in hemophilia A plasma

Posted by | Jul 31, 2019 | |

Maria Isabel Bravo1, Aida Raventos1, Alba Perez1, Montserrat Costa1, Todd Willis21Discovery...

Read More